{"id":50604,"date":"2023-09-20T09:10:55","date_gmt":"2023-09-20T09:10:55","guid":{"rendered":"https:\/\/medsname.com\/glucobay\/"},"modified":"2026-05-01T10:49:11","modified_gmt":"2026-05-01T10:49:11","slug":"glucobay","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/glucobay\/","title":{"rendered":"Glucobay"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Glucobay?<\/h3>\n<p style=\"margin:0;\"><strong>Glucobay<\/strong> este o marc\u0103 a <strong>acarbose<\/strong> (25 mg sau 50 mg), un <strong>inhibitor alfa-glucosidaz\u0103<\/strong> utilizat pentru <strong>diabetului de tip 2<\/strong> \u0219i prediabet. Ac\u021bioneaz\u0103 <em>\u00een intestin<\/em>: \u00eencetine\u0219te descompunerea carbohidra\u021bilor complec\u0219i \u00een glucoz\u0103, reduc\u00e2nd v\u00e2rful glicemic postprandial. Nu <strong>prime\u0219te,<\/strong> provoac\u0103 hipoglicemie de la sine. Reducere HbA1c: 0,5\u20130,8 puncte procentuale \u2014 modest\u0103, dar util\u0103 \u00een special pentru persoanele cu glicemie postprandial\u0103 ridicat\u0103 (\u0219i glicemie la nem\u00e2ncat normal\u0103). Lua\u021bi comprimatul chiar la prima \u00eenghi\u021bitur\u0103 din fiecare mas\u0103 principal\u0103. Inhib\u0103 at\u00e2t alfa-amilaza, c\u00e2t \u0219i alfa-glucosidaza \u2014 cea mai larg\u0103 ac\u021biune de blocare a carbohidra\u021bilor din clas\u0103. Efectele secundare principale sunt exclusiv gastrointestinale: flatulen\u021b\u0103, balonare, diaree (se \u00eembun\u0103t\u0103\u021be\u0219te dup\u0103 2\u20134 s\u0103pt\u0103m\u00e2ni la titrare gradual\u0103). Evita\u021bi \u00een boala inflamatorie intestinal\u0103, tulbur\u0103ri intestinale cronice, insuficien\u021b\u0103 renal\u0103 sever\u0103 \u0219i sarcin\u0103.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Glucobay?<\/h2>\n<p>Glucobay este un medicament antidiabetic oral care con\u021bine <strong>acarbose<\/strong> (25 mg sau 50 mg), fabricat de Bayer India. Disponibil \u00een cutii de 30, 60, 90 sau 180 de comprimate. Acarboza este un <strong>inhibitor alfa-glucosidaz\u0103<\/strong> \u2014 o clas\u0103 care ac\u021bioneaz\u0103 local \u00een intestinul sub\u021bire pentru a \u00eencetini digestia carbohidra\u021bilor. Aprobat pentru prima dat\u0103 \u00een 1990 (UE) \/ 1995 (SUA). Utilizat pe scar\u0103 larg\u0103 \u00een Asia de Est pentru controlul glicemiei postprandiale; marca original\u0103 Glucobay (Bayer).<\/p>\n<p>Inhibitorii alfa-glucosidazei sunt potrivi\u021bi pentru pacien\u021bii a c\u0103ror problem\u0103 principal\u0103 este <strong>cre\u0219teri ale glicemiei postprandiale<\/strong> (\u00een special la diete bogate \u00een carbohidra\u021bi) \u00een timp ce glicemia la nem\u00e2ncat este aproape normal\u0103 \u2014 un model comun \u00een popula\u021biile asiatice.<\/p>\n<h2 class=\"wp-block-heading\">Cum func\u021bioneaz\u0103 Glucobay?<\/h2>\n<p>C\u00e2nd consuma\u021bi o mas\u0103 bogat\u0103 \u00een carbohidra\u021bi, enzimele din intestinul sub\u021bire (alfa-amilaza \u0219i alfa-glucosidazele de la bordura peretelui intestinal) descompun carbohidra\u021bii complec\u0219i \u00een zaharuri simple (glucoz\u0103) care pot fi apoi absorbite \u00een s\u00e2nge.<\/p>\n<p>acarbose <strong>inhib\u0103 competitiv<\/strong> acele enzime. Efectul este:<\/p>\n<ul>\n<li>\u00cent\u00e2rzierea digestiei carbohidra\u021bilor \u2014 glucoza este eliberat\u0103 mai gradual \u00een decurs de 2\u20133 ore dup\u0103 mas\u0103<\/li>\n<li>Sc\u0103derea v\u00e2rfului de glucoz\u0103 postprandial\u0103 (cu 40\u201360 mg\/dL \u00een medie)<\/li>\n<li>Cerin\u021b\u0103 redus\u0103 de eliberare postprandial\u0103 de insulin\u0103 \u2014 poate conserva func\u021bia celulelor beta pe termen lung<\/li>\n<li>Niciun efect direct asupra glicemiei sau eliber\u0103rii de insulin\u0103 \u00een stare de post \u2014 deci <strong>f\u0103r\u0103 hipoglicemie<\/strong> ca monoterapie<\/li>\n<\/ul>\n<p>Deoarece medicamentul ac\u021bioneaz\u0103 \u00een \u00eentregime \u00een lumenul intestinal (absorb\u021bia sistemic\u0103 este minim\u0103 pentru acarboz\u0103 \u0219i vogliboz\u0103), are foarte pu\u021bine efecte adverse sistematice. Reducere tipic\u0103 a HbA1c: <strong>0,5\u20130,8 puncte procentuale<\/strong>. Glicemia \u00een stare de post r\u0103m\u00e2ne practic neschimbat\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Doza \u0219i administrare<\/h2>\n<p><strong>Doza:<\/strong> 25 mg de trei ori pe zi cu prima \u00eenghi\u021bitur\u0103 din fiecare mas\u0103 principal\u0103. Titra\u021bi la fiecare 4\u20138 s\u0103pt\u0103m\u00e2ni \u00een pa\u0219i de 25 mg. Doza de \u00eentre\u021binere obi\u0219nuit\u0103: 50\u2013100 mg de trei ori pe zi. Maxim 300 mg\/zi.<\/p>\n<ul>\n<li><strong>Lua\u021bi cu prima \u00eenghi\u021bitur\u0103 din mas\u0103.<\/strong> Administrarea dup\u0103 mas\u0103 este mult mai pu\u021bin eficient\u0103 \u2014 enzimele ac\u021bioneaz\u0103 deja.<\/li>\n<li><strong>\u00cencepe\u021bi cu doze mici, titra\u021bi \u00eencet.<\/strong> Cel mai frecvent motiv pentru \u00eentrerupere sunt efectele adverse gastrointestinale. \u00cenceperea cu cea mai mic\u0103 doz\u0103 \u0219i titrarea progresiv\u0103 pe 4\u20138 s\u0103pt\u0103m\u00e2ni \u00eembun\u0103t\u0103\u021be\u0219te semnificativ tolerabilitatea.<\/li>\n<li>Omite\u021bi doza dac\u0103 omite\u021bi masa.<\/li>\n<li><strong>Tratamentul hipoglicemiei:<\/strong> dac\u0103 apare hipoglicemie \u00een terapie combinat\u0103 (cu sulfoniluree sau insulin\u0103), folosi\u021bi <strong>glucoz\u0103 pur\u0103 (dextroz\u0103)<\/strong> \u2014 <em>prime\u0219te,<\/em> zaharoza, p\u00e2inea sau sucul de fructe. Inhibitorii alfa-glucosidazei blocheaz\u0103 descompunerea zaharozei, a\u0219a c\u0103 zah\u0103rul de mas\u0103 ac\u021bioneaz\u0103 prea \u00eencet.<\/li>\n<li><strong>Renal:<\/strong> evita\u021bi dac\u0103 eGFR &lt; 25\u201330.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p>Aproape toate efectele adverse sunt gastrointestinale \u0219i datorate carbohidra\u021bilor neabsorbi\u021bi care fermenteaz\u0103 \u00een colon:<\/p>\n<p><strong>Frecvente (p\u00e2n\u0103 la 30% \u00een primele s\u0103pt\u0103m\u00e2ni; se \u00eembun\u0103t\u0103\u021be\u0219te la &lt; 10% cu titrare lent\u0103):<\/strong><\/p>\n<ul>\n<li>Flatulen\u021b\u0103<\/li>\n<li>Umflare, disconfort abdominal<\/li>\n<li>Scaune moi sau diaree<\/li>\n<li>Borborigmi (zgomote intestinale audibile)<\/li>\n<\/ul>\n<p><strong>Mai pu\u021bin frecvente:<\/strong> cre\u0219teri tranzitorii ale enzimelor hepatice (\u00een special la doze mari de acarboz\u0103), erup\u021bii cutanate, hipersensibilitate.<\/p>\n<p>Deoarece acarboza nu stimuleaz\u0103 eliberarea de insulin\u0103, nu <strong>prime\u0219te,<\/strong> provoac\u0103 hipoglicemie singur\u0103. Riscul de hipoglicemie apare doar atunci c\u00e2nd este combinat\u0103 cu o sulfoniluree, meglitinid\u0103 sau insulin\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Preparate cu enzime digestive (pancreatin\u0103, amilaz\u0103)<\/strong> \u2014 contracareaz\u0103 efectul medicamentului; nu combina\u021bi.<\/li>\n<li><strong>Sulfoniluree, meglitinide, insulin\u0103<\/strong> \u2014 efect aditiv de sc\u0103dere a glicemiei cu risc de hipoglicemie. Folosi\u021bi <em>glucoz\u0103 (dextroz\u0103)<\/em>, nu zah\u0103r din trestie, pentru tratarea unei hipoglicemii.<\/li>\n<li><strong>Diuretice tiazidice, corticoesteroide, hormoni tiroidieni<\/strong> \u2014 pot reduce efectul hipoglicemiant.<\/li>\n<li><strong>Digoxin\u0103<\/strong> \u2014 acarboza poate reduce absorb\u021bia digoxinului; separa\u021bi cu 2 ore.<\/li>\n<li><strong>Neomicin\u0103, antibiotice care afecteaz\u0103 flora intestinal\u0103<\/strong> \u2014 pot agrava efectele adverse gastrointestinale.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Cine nu ar trebui s\u0103 ia Glucobay?<\/h2>\n<ul>\n<li>Boal\u0103 inflamatorie intestinal\u0103 (boala Crohn, colit\u0103 ulcerativ\u0103)<\/li>\n<li>Tulbur\u0103ri intestinale cronice, obstruc\u021bie intestinal\u0103 par\u021bial\u0103<\/li>\n<li>Sindroame de malabsorb\u021bie<\/li>\n<li>Hernii hiatale mari sau afec\u021biuni agravate de formarea crescut\u0103 de gaze<\/li>\n<li>Insuficien\u021b\u0103 renal\u0103 sever\u0103 (eGFR &lt; 25\u201330)<\/li>\n<li>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103<\/li>\n<li>Sarcin\u0103 \u0219i al\u0103ptare<\/li>\n<li>Copii (siguran\u021ba nu a fost stabilit\u0103)<\/li>\n<li>Cetoacidoz\u0103 diabetic\u0103<\/li>\n<li>Hipersensibilitate cunoscut\u0103<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>P\u0103stra\u021bi Glucobay sub 25\u00b0C \u00eentr-un loc uscat, \u00een blisterul original. Depozita\u021bi \u00eentr-un loc inaccesibil copiilor.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Este acarbos\u0103 mai bun\u0103 dec\u00e2t vogliboz\u0103 sau miglitol?<\/h3>\n<p>To\u021bi cei trei inhibitori de alfa-glucosidaz\u0103 au un efect similar asupra HbA1c (0,5\u20130,8 puncte) \u0219i \u021binte identice. Acarbosa are cea mai solid\u0103 baz\u0103 de dovezi (inclusiv studiul STOP-NIDDM pentru prediabet), dar \u0219i cele mai multe efecte adverse gastrointestinale (flatulen\u021b\u0103, diaree). Vogliboza produce mai pu\u021bine tulbur\u0103ri gastrointestinale \u0219i este popular\u0103 \u00een Japonia \u0219i India. Miglitolul are o absorb\u021bie sistemic\u0103 u\u0219or mai bun\u0103.<\/p>\n<h3 class=\"wp-block-heading\">De ce am at\u00e2t de multe gaze cu Glucobay?<\/h3>\n<p>Deoarece carbohidra\u021bii neabsorbi\u021bi ajung \u00een colon, unde bacteriile intestinale le fermenteaz\u0103 \u00een gaze (hidrogen, metan, CO<sub>2<\/sub>). Acest lucru este normal \u0219i de obicei se \u00eembun\u0103t\u0103\u021be\u0219te \u00een 2\u20134 s\u0103pt\u0103m\u00e2ni dac\u0103 titra\u021bi lent. Consumul mai redus de dulciuri \u0219i zah\u0103r \u00een perioada de adaptare ajut\u0103 de asemenea.<\/p>\n<h3 class=\"wp-block-heading\">Poate Glucobay s\u0103 m\u0103 ajute s\u0103 sl\u0103besc?<\/h3>\n<p>Moderat, dac\u0103 deloc \u2014 inhibitorii de alfa-glucosidaz\u0103 sunt neutri din punct de vedere al greut\u0103\u021bii sau duc la o sc\u0103dere u\u0219oar\u0103 a greut\u0103\u021bii (0,5\u20131,5 kg). Inhibitorii SGLT-2 \u0219i agonistii GLP-1 sunt agen\u021bi mult mai puternici pentru pierderea \u00een greutate.<\/p>\n<h3 class=\"wp-block-heading\">Glucobay provoac\u0103 hipoglicemie?<\/h3>\n<p>Nu de unul singur. Atunci c\u00e2nd este combinat cu o sulfoniluree sau insulin\u0103, combina\u021bia poate provoca hipoglicemie \u2014 \u0219i atunci este important s\u0103 folosi\u021bi <strong>comprimate de glucoz\u0103 sau dextroz\u0103<\/strong>, nu zah\u0103r din mas\u0103, deoarece acarbosa blocheaz\u0103 digestia zaharurorii.<\/p>\n<h3 class=\"wp-block-heading\">Poate fi folosit Glucobay pentru prediabet?<\/h3>\n<p>Acarbosa are dovezi solide \u00een prediabet (studiu STOP-NIDDM a ar\u0103tat o reducere cu 36% a progresiei c\u0103tre diabet de tip 2) \u0219i este utilizat\u0103 off-label pentru aceast\u0103 indica\u021bie \u00een unele regiuni. Metformina este de obicei prima alegere.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Glucobay online?<\/h3>\n<p>Pute\u021bi comanda Glucobay (25 mg sau 50 mg) de la MedsBase \u00een cutii de 30, 60, 90 sau 180 de comprimate. Livr\u0103m \u00een \u00eentreaga lume, cu ambalaj discret \u0219i stoc autentic certificat WHO-GMP de la produc\u0103tor.<\/p>\n<h2 class=\"wp-block-heading\">Medicamente \u00eenrudite pentru Diabet<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glucobay\/\">Glucobay \u2014 Acarbose 25\/50 mg (Bayer)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/voglibite\/\">Voglibite \u2014 Voglibose 0.2\/0.3 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ppg\/\">PPG \u2014 Voglibose (Abbott)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/mignar\/\">Mignar \u2014 Miglitol (Glenmark)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glycomet-sr\/\">Glycomet SR \u2014 Metformin cu eliberare prelungit\u0103<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/januvia\/\">Januvia \u2014 Sitagliptin\u0103 (inhibitor DPP-4)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/diabetes-medication\/\"><strong>Vizualiza\u021bi toate Medicamentele pentru Diabet<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are doar scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui profesionist calificat din domeniul s\u0103n\u0103t\u0103\u021bii. Inhibitorii alfa-glucosidazei sunt contraindica\u021bi \u00een boala inflamatorie intestinal\u0103 \u0219i tulbur\u0103ri intestinale cronice \u2014 utiliza\u021bi \u00eentotdeauna sub \u00eendrumare medical\u0103.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/app-up\/\">App-Up<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/biodib-30\/\">Biodib 30<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/pexopram-0-5\/\">Pexopram 0.5<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/r-cin\/\">R-Cin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/gravitor\/\">Gravitor<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<h5>\u2705 Ajut\u0103 la controlul glicemiei<br \/>\n\u2705 Gestioneaz\u0103 cre\u0219terile glicemice postprandiale<br \/>\n\u2705 Sprijin\u0103 managementul greut\u0103\u021bii<br \/>\n\u2705 Reduce complica\u021biile asociate diabetului<\/h5>\n<p><span style=\"color: #999999;\">Glucobay con\u021bine Acarbose<\/span><\/p>","protected":false},"featured_media":50605,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[3247,3248],"class_list":{"0":"post-50604","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-acarbose","11":"product_tag-glucobay","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/50604","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=50604"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/50605"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=50604"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=50604"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=50604"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=50604"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}